Showing results 8 to 27 of 79
< previous
next >
Issue Date | Title | Author(s) |
2018 | Cannabis for pediatric epilepsy: Protocol for a living systematic review | Elliott, J; DeJean, D; Clifford, T; Coyle, D; Potter, B; Skidmore, B; Alexander, C; Repetski, AE; McCoy, B; Wells, GA |
2016 | Child and family experiences with inborn errors of metabolism: a qualitative interview study with representatives of patient groups | Tingley, K; Chakraborty, P; Coyle, D; Kronick, JB; Laberge, A-M; Little, J; Miller, FA; Mitchell, JJ; Prasad, C; Siddiq, S; Siriwardena, K; Sparkes, R; Speechley, KN; Stockler, S; Trakadis, Y; Wilson, BJ; Wilson, K; Potter, BK |
1-Oct-2018 | COMPARING A DIRECT AND STAGED APPROACH TO ITEM SELECTION IN A MULTI-DIMENSIONAL PATIENT-REPORTED OUTCOME MEASURE | Singh, J; Pokhrel, S; Coyle, D; Longworth, L |
2013 | Computed tomographic coronary angiography for patients with heart failure (CTA-HF): A randomized controlled trial (IMAGE HF Project 1-C) | Chow, BJW; Green, RE; Coyle, D; Laine, M; Hanninen, H; Leskinen, H; Rajda, M; Larose, E; Hartikainen, J; Hedman, M; Mielniczuk, L; O'Meara, E; deKemp, RA; Klein, R; Paterson, I; White, JA; Yla-Herttuala, S; Leber, A; Tandon, V; Lee, T; Al-Hesayen, A; Hessian, R; Dowsley, T; Kass, M; Kelly, C; Garrard, L; Tardif, J-C; Knuuti, J; Beanlands, RS; Wells, GA |
26-Jun-2020 | Computed tomography coronary angiography for patients with heart failure (CTA-HF): a randomized controlled trial (IMAGE-HF 1C) | Chow, BJW; Coyle, D; Hossain, A; Laine, M; Hanninen, H; Ukkonen, H; Rajda, M; Larose, E; Hartikainen, J; Mielniczuk, L; Kass, M; Connelly, KA; O'Meara, E; Garrard, L; Bishop, H; Small, G; Hedman, M; Coyle, K; Yla-Herttuala, S; Knuuti, J; Wells, GA; Beanlands, RS |
2011 | (Correcting) misdiagnoses of asthma: A cost effectiveness analysis | Pakhale, S; Sumner, A; Coyle, D; Vandemheen, K; Aaron, S |
2016 | Cost Analysis of Universal Screening vs. Risk Factor-Based Screening for Methicillin-Resistant Staphylococcus aureus (MRSA) | Roth, VR; Longpre, T; Coyle, D; Suh, KN; Taljaard, M; Muldoon, KA; Ramotar, K; Forster, A |
2014 | Cost effectiveness of a survivorship care plan for breast cancer survivors | Coyle, D; Grunfeld, E; Coyle, K; Pond, G; Julian, JA; Levine, MN |
2016 | Cost effectiveness of first-line oral therapies for pulmonary arterial hypertension: A modelling study | Coyle, K; Coyle, D; Blouin, J; Lee, K; Jabr, MF; Tran, K; Mielniczuk, L; Swiston, J; Innes, M |
2017 | Cost effectiveness of the addition of a comprehensive CT scan to the abdomen and pelvis for the detection of cancer after unprovoked venous thromboembolism | Coyle, K; Carrier, M; Lazo-Langner, A; Shivakumar, S; Zarychanski, R; Tagalakis, V; Solymoss, S; Routhier, N; Douketis, J; Coyle, D |
21-Nov-2020 | Cost-effectiveness of a gestational age metabolic algorithm for preterm and small-for-gestational-age classification | Coyle, K; Quan, AML; Wilson, LA; Hawken, S; Bota, AB; Coyle, D; Murray, JC; Wilson, K |
2017 | Cost-effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMOD | Trapero-Bertran, M; Muñoz, C; Coyle, K; Coyle, D; Lester-George, A; Leidl, R; Nemeth, B; Cheung, KL; Pokhrel, S; Lopez-Nicolás, A |
2019 | Cost-effectiveness of cannabinoids for pediatric drug-resistant epilepsy: Protocol for a systematic review of economic evaluations | Elliott, J; McCoy, B; Clifford, T; Potter, BK; Skidmore, B; Wells, GA; Coyle, D |
2017 | Cost-effectiveness of increasing the reach of smoking cessation interventions in Germany: results from the EQUIPTMOD | Huber, M; Präger, M; Coyle, K; Coyle, D; Lester-George, A; Trapero-Bertran, M; Nemeth, B; Cheung, KL; Stark, R; Vogl, M; Pokhrel, S; Leidl, R |
12-Aug-2022 | Cost-effectiveness of integrated disease management for high risk, exacerbation prone, patients with chronic obstructive pulmonary disease in a primary care setting | Scarffe, AD; Licskai, CJ; Ferrone, M; Brand, K; Thavorn, K; Coyle, D |
30-Jan-2018 | Cost-Effectiveness of Pharmacological Treatments for Osteoporosis Consistent with the Revised Economic Evaluation Guidelines for Canada. | Coyle, D |
2017 | A cost-utility analysis of risk model-guided versus physician’s choice antiemetic prophylaxis in patients receiving chemotherapy for early-stage breast cancer: a net benefit regression approach | Coyle, D; Hoch, JS; Vandermeer, L; Mazzarello, S; Wang, Z; Dranitsaris, G; Fergusson, D; Clemons, M |
2016 | Costs of disinvesting from stop smoking services: an economic evaluation based on the NICE Tobacco Return on Investment model | Pokhrel, S; Owen, L; Coyle, K; Lester-George, A; Leng, G; West, R; Coyle, D |
2016 | Designing economic evaluations to facilitate optimal decisions: The need to avoid bias | Lee, KM; Coyle, K; Coyle, D |
2010 | Determining utility values related to malaria and malaria chemoprophylaxis | McCarthy, AE; Coyle, D |